IGF-1 LR3

IGF-1 LR3 Product Description — Research Use Only

IGF-1 LR3, also known as Long R3 Insulin-Like Growth Factor-1, is a synthetic research peptide analog of IGF-1. It is commonly studied for IGF-1 receptor activity, cellular growth signaling, protein-balance pathways, tissue-repair research, glucose-transport activity, and muscle-cell development models.

Research on IGF-1 LR3 has most commonly focused on IGF-1 receptor signaling, cellular growth pathways, protein synthesis, muscle-cell research, tissue repair, metabolic activity, and cell-survival signaling. Published structural research describes Long-[Arg3]IGF-I as a potent IGF-I analog modified with an arginine substitution at position 3 and a 13-amino-acid extension at the N-terminus.

IGF-1 LR3 is commonly studied for:

• IGF-1 receptor activity — how the compound interacts with IGF-1 receptor pathways

• Cell growth signaling — how cells respond to growth-related signals

• Protein synthesis — pathways connected to building and maintaining proteins

• Muscle-cell research — how muscle cells grow, repair, and adapt in research settings

• Tissue-repair pathways — biological signals involved in repair and restoration

• Glucose transport — how cells move and use glucose for energy

• Cell survival signaling — how cells respond to stress and maintain normal activity

IGF-1 LR3 is commonly studied because it is a modified form of IGF-1 designed for stronger and longer-lasting receptor-pathway research compared with native IGF-1. IGF-1 receptor biology is broadly connected to cell growth, differentiation, survival, and metabolic regulation, making IGF-1 LR3 useful in studies involving growth-factor signaling and repair-related pathways.

For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.